Haematology Research Laboratory, St Vincent's Hospital, Sydney, Australia.
Thromb Res. 2010 Oct;126(4):328-36. doi: 10.1016/j.thromres.2010.06.028. Epub 2010 Aug 3.
To investigate the effects of Sodium Tetradecyl Sulphate (STS) and Polidocanol (POL) on fibrinolytic mechanisms.
Measurements were done with serial dilutions of sclerosants in whole blood (WB), platelet rich (PRP) and platelet poor plasma (PPP). Control experiments were done in 5% bovine serum albumin (BSA), spiked with the enzyme/inhibitor. Plasminogen was measured with a chromogenic assay. Alpha-2-antiplasmin (AP) activity, plasmin-alpha-2-antiplasmin (PAP) complexes, plasminogen activator inhibitor-1 (PAI-1) activity, tissue plasminogen activator (t-PA) total antigen, t-PA activity, t-PA/PAI-1 complexes, thrombin activatable fibrinolysis inhibitor (TAFI) antigen and activated TAFI (TAFIa) were measured by ELISA.
At high concentrations (>0.3%), STS destroyed plasminogen, PAI-1, t-PA/PAI-1 complexes and total t-PA antigen but increased t-PA activity. At low concentrations (<0.3%), both agents reduced PAP complexes while increasing AP activity. Low concentration STS increased PAI-1 activity, t-PA/PAI-1 complexes, TAFI and TAFIa. Low concentration POL mildly increased the total t-PA antigen and TAFI.
At low concentrations, both agents demonstrated a prothrombotic, antifibrinolytic (increase in PAI-1, total t-PA antigen, AP, TAFI and TAFIa) activity. At high concentrations, STS demonstrated non-prothrombotic (destruction of PAI-1, t-PA/PAI-1 complexes), antifibrinolytic (destruction of plasminogen, increase in AP) activity while POL had minimal effect.
研究十四烷基硫酸钠(STS)和聚多卡醇(POL)对纤维蛋白溶解机制的影响。
在全血(WB)、富含血小板的(PRP)和血小板贫乏的血浆(PPP)中,用硬化剂的系列稀释液进行测量。在 5%牛血清白蛋白(BSA)中进行对照实验,用酶/抑制剂加标。用显色测定法测量纤溶酶原。用 ELISA 测量α-2-抗纤溶酶(AP)活性、纤溶酶-α-2-抗纤溶酶(PAP)复合物、纤溶酶原激活物抑制剂-1(PAI-1)活性、组织型纤溶酶原激活物(t-PA)总抗原、t-PA 活性、t-PA/PAI-1 复合物、凝血酶激活的纤溶抑制物(TAFI)抗原和激活的 TAFI(TAFIa)。
在高浓度(>0.3%)下,STS 破坏纤溶酶原、PAI-1、t-PA/PAI-1 复合物和总 t-PA 抗原,但增加 t-PA 活性。在低浓度(<0.3%)下,两种药物均减少 PAP 复合物,同时增加 AP 活性。低浓度 STS 增加 PAI-1 活性、t-PA/PAI-1 复合物、TAFI 和 TAFIa。低浓度 POL 轻度增加总 t-PA 抗原和 TAFI。
在低浓度下,两种药物均表现出促血栓形成、抗纤维蛋白溶解(增加 PAI-1、总 t-PA 抗原、AP、TAFI 和 TAFIa)活性。在高浓度下,STS 表现出非促血栓形成(破坏 PAI-1、t-PA/PAI-1 复合物)、抗纤维蛋白溶解(破坏纤溶酶原、增加 AP)活性,而 POL 影响较小。